• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产后使用类固醇减少,支气管肺发育不良增多:一项基于人群的极低出生体重儿研究

Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants.

作者信息

Shinwell E S, Lerner-Geva L, Lusky A, Reichman B

机构信息

Department of Neonatology, Kaplan Medical Center, Rehovot, Hadassah Medical School, Hebrew University, Jerusalem, Israel. eric_

出版信息

Arch Dis Child Fetal Neonatal Ed. 2007 Jan;92(1):F30-3. doi: 10.1136/adc.2006.094474. Epub 2006 Jun 12.

DOI:10.1136/adc.2006.094474
PMID:16769711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2675295/
Abstract

OBJECTIVE

To study the association between reduced use of postnatal steroids for bronchopulmonary dysplasia (BPD) in very low birthweight (VLBW) infants and oxygen (O(2))-dependency at 28 days of age and at 36 weeks postmenstrual age.

DESIGN

Large national database study.

SETTING

The Israel National VLBW Neonatal Database.

PATIENTS

The sample included infants born between 1997 and 2004, of gestational age 24-32 weeks, who required mechanical ventilation or O(2) therapy. Four time periods were compared: 1997-8 (era 1, peak use), 1999-2000 (era 2, intermediate), 2001-2 (era 3, expected reduction) and 2003-4 (era 4, lowest). The outcome variable "oxygen dependency" was based on clinical criteria. Multivariate regression models were used to account for confounding variables.

RESULTS

Steroid use fell significantly from 23.5% in 1997-8 to 11% in 2003-4 (p<0.005). After adjustment for relevant confounding variables, the odds ratio for O(2) therapy at 28 days in era 4 versus era 1 was 1.75, 95% confidence interval (CI) 1.47 to 2.09 and 1.41, 95% CI 1.15 to 1.73 at 36 weeks postmenstrual age. The mean duration of O(2) therapy increased from 25.3 days (95% CI 23.3 to 26.3) in era 1, to 28.0 days (95% CI 26.6 to 29.4) in era 4. Survival increased from 78.5% in era 1 to 81.6% in era 4 (p<0.005).

CONCLUSIONS

The use of steroids has fallen considerably since the awareness of the adverse effects of this treatment. This change has been temporally associated with increased O(2) dependency at 28 days of age and at 36 weeks postmenstrual age. The prolongation of O(2) therapy was modest in degree.

摘要

目的

研究极低出生体重(VLBW)婴儿支气管肺发育不良(BPD)产后类固醇使用减少与28日龄及月经后36周时对氧(O₂)依赖之间的关联。

设计

大型国家数据库研究。

设置

以色列国家极低出生体重新生儿数据库。

患者

样本包括1997年至2004年间出生、胎龄24 - 32周、需要机械通气或O₂治疗的婴儿。比较了四个时间段:1997 - 1998年(时期1,使用高峰)、1999 - 2000年(时期2,中等)、2001 - 2002年(时期3,预期减少)和2003 - 2004年(时期4,最低)。结局变量“氧依赖”基于临床标准。使用多变量回归模型来考虑混杂变量。

结果

类固醇使用从1997 - 1998年的23.5%显著降至2003 - 2004年的11%(p<0.005)。在对相关混杂变量进行调整后,时期4与时期1相比,28日龄时接受O₂治疗的比值比为1.75,95%置信区间(CI)为1.47至2.09;月经后36周时为1.41,95%CI为1.15至1.73。O₂治疗的平均持续时间从时期1的25.3天(95%CI 23.3至26.3)增加到时期4的28.0天(95%CI 26.6至29.4)。存活率从时期1的78.5%增加到时期4的81.6%(p<0.005)。

结论

自认识到这种治疗的不良反应以来,类固醇的使用已大幅下降。这一变化在时间上与28日龄及月经后36周时氧依赖增加相关。O₂治疗延长的程度较小。

相似文献

1
Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants.产后使用类固醇减少,支气管肺发育不良增多:一项基于人群的极低出生体重儿研究
Arch Dis Child Fetal Neonatal Ed. 2007 Jan;92(1):F30-3. doi: 10.1136/adc.2006.094474. Epub 2006 Jun 12.
2
Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.吸入性糖皮质激素与全身性糖皮质激素预防机械通气的极低出生体重早产儿支气管肺发育不良的比较
Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD002058. doi: 10.1002/14651858.CD002058.pub3.
3
Candidal versus bacterial late-onset sepsis in very low birthweight infants in Israel: a national survey.以色列极低出生体重儿念珠菌与细菌迟发性败血症的全国性调查。
J Hosp Infect. 2007 Mar;65(3):237-43. doi: 10.1016/j.jhin.2006.12.004. Epub 2007 Feb 2.
4
Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.基于人群的队列研究中医院变异与支气管肺发育不良的危险因素。
JAMA Pediatr. 2015 Feb;169(2):e143676. doi: 10.1001/jamapediatrics.2014.3676. Epub 2015 Feb 2.
5
Population-based study of bronchopulmonary dysplasia in very low birth weight infants in Switzerland.瑞士极低出生体重儿支气管肺发育不良的基于人群的研究。
Eur J Pediatr. 2005 May;164(5):292-7. doi: 10.1007/s00431-005-1623-1. Epub 2005 Feb 15.
6
Need for supplemental oxygen at discharge in infants with bronchopulmonary dysplasia is not associated with worse neurodevelopmental outcomes at 3 years corrected age.支气管肺发育不良患儿出院时需要补充氧气与 3 校正年龄时的神经发育结局较差无关。
PLoS One. 2014 Mar 19;9(3):e90843. doi: 10.1371/journal.pone.0090843. eCollection 2014.
7
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.吸入或滴注类固醇用于预防支气管肺发育不良。
Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5.
8
Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns.早期累积补充氧气可预测高危极早产儿的支气管肺发育不良
J Pediatr. 2016 Oct;177:97-102.e2. doi: 10.1016/j.jpeds.2016.06.079. Epub 2016 Jul 26.
9
Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.晚期(>7天)全身性产后皮质类固醇用于预防早产儿支气管肺发育不良
Cochrane Database Syst Rev. 2017 Oct 24;10(10):CD001145. doi: 10.1002/14651858.CD001145.pub4.
10
Frequency and clinical correlates of radiographic patterns of bronchopulmonary dysplasia in very low birth weight infants by term age.按矫正胎龄评估极低出生体重儿支气管肺发育不良的放射学模式的频率和临床相关性。
Eur J Pediatr. 2012 Jan;171(1):95-102. doi: 10.1007/s00431-011-1486-6. Epub 2011 May 20.

引用本文的文献

1
Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.皮质类固醇预防和治疗支气管肺发育不良:系统评价概述。
Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD013271. doi: 10.1002/14651858.CD013271.pub2.
2
Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.全身皮质类固醇方案预防早产儿支气管肺发育不良。
Cochrane Database Syst Rev. 2023 Mar 13;3(3):CD010941. doi: 10.1002/14651858.CD010941.pub3.
3
Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis.皮质类固醇预防早产儿支气管肺发育不良的疗效:网状 Meta 分析。
Arch Dis Child Fetal Neonatal Ed. 2018 Nov;103(6):F506-F511. doi: 10.1136/archdischild-2017-313759. Epub 2018 Feb 23.
4
Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.用于预防早产儿支气管肺发育不良的全身皮质类固醇治疗方案。
Cochrane Database Syst Rev. 2017 Jan 31;1(1):CD010941. doi: 10.1002/14651858.CD010941.pub2.
5
Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study.欧洲孕龄小于30周早产儿基于证据的新生儿重症监护病房实践及产后使用皮质类固醇的决定因素。一项基于人群的队列研究。
PLoS One. 2017 Jan 23;12(1):e0170234. doi: 10.1371/journal.pone.0170234. eCollection 2017.
6
Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.系统地给予氢化可的松预防早产儿支气管肺发育不良(SToP-BPD 研究):一项多中心随机安慰剂对照试验。
BMC Pediatr. 2011 Nov 9;11:102. doi: 10.1186/1471-2431-11-102.
7
Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?靶向炎症反应以预防支气管肺发育不良:新的见解能否转化为治疗方法?
Pediatrics. 2011 Jul;128(1):111-26. doi: 10.1542/peds.2010-3875. Epub 2011 Jun 6.
8
Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants.出生后使用皮质类固醇对矫正年龄18至22个月时神经发育的影响:极低出生体重儿的剂量、时机及支气管肺发育不良风险的影响
Pediatrics. 2009 Mar;123(3):e430-7. doi: 10.1542/peds.2008-1928. Epub 2009 Feb 9.
9
A comparison of Wisconsin neonatal intensive care units with national data on outcomes and practices.威斯康星州新生儿重症监护病房与全国结局及实践数据的比较。
WMJ. 2008 Nov;107(7):320-6.
10
Postnatal corticosteroids for bronchopulmonary dysplasia.用于支气管肺发育不良的产后皮质类固醇激素。
Clin Perinatol. 2009 Mar;36(1):177-88. doi: 10.1016/j.clp.2008.09.016.

本文引用的文献

1
Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.低剂量地塞米松有助于长期依赖呼吸机的婴儿脱机:一项多中心、国际、随机、对照试验。
Pediatrics. 2006 Jan;117(1):75-83. doi: 10.1542/peds.2004-2843.
2
Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants.治疗前的皮质醇值可能预测高危婴儿使用氢化可的松预防支气管肺发育不良的反应。
J Pediatr. 2005 May;146(5):632-7. doi: 10.1016/j.jpeds.2004.12.040.
3
Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002.1994年至2002年间重度支气管肺发育不良的发生率趋势
J Pediatr. 2005 Apr;146(4):469-73. doi: 10.1016/j.jpeds.2004.12.023.
4
Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease.产后全身使用皮质类固醇对早产儿死亡率和脑瘫的影响:慢性肺病风险的效应修正
Pediatrics. 2005 Mar;115(3):655-61. doi: 10.1542/peds.2004-1238.
5
Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial.预防早期肾上腺功能不全以防止支气管肺发育不良:一项多中心试验。
Pediatrics. 2004 Dec;114(6):1649-57. doi: 10.1542/peds.2004-1159.
6
Impact of a physiologic definition on bronchopulmonary dysplasia rates.生理定义对支气管肺发育不良发生率的影响。
Pediatrics. 2004 Nov;114(5):1305-11. doi: 10.1542/peds.2004-0204.
7
N-acetylcysteine administration during the first week of life does not improve lung function in extremely low birth weight infants.出生后第一周给予N-乙酰半胱氨酸并不能改善极低出生体重儿的肺功能。
Biol Neonate. 2004;86(4):275-9. doi: 10.1159/000080089. Epub 2004 Aug 5.
8
Current dilemmas in postnatal steroid therapy for chronic lung disease in preterm infants.
Biol Neonate. 2003;84(1):96-100. doi: 10.1159/000071011.
9
Implementing potentially better practices to improve neonatal outcomes after reducing postnatal dexamethasone use in infants born between 501 and 1250 grams.在减少出生体重501至1250克婴儿产后地塞米松使用后,实施可能更好的措施以改善新生儿结局。
Pediatrics. 2003 Apr;111(4 Pt 2):e534-41.
10
Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase.出生时接受重组人铜锌超氧化物歧化酶治疗的早产儿1岁矫正年龄时的肺部转归
Pediatrics. 2003 Mar;111(3):469-76. doi: 10.1542/peds.111.3.469.